There Is No Association Between Patient Outcomes and Demographics in an Open-Label Safety and Efficacy Study of RBX2660, a Microbiota-Based Drug for Recurrent Clostridium difficile Infection Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Ray, Arnab
  • Hecht, Gail
  • Orenstein, Robert
  • Lee, Christine
  • Dubberke, Erik
  • Khanna, Sahil
  • Blount, Ken

publication date

  • October 1, 2017